GreenLight XPS for treating benign prostatic hyperplasia (HTG650)Product type:GuidanceProgramme:HealthTech guidancePublished: 29 November 2022
Optilume for treating recurrent bulbar urethral strictures (HTG649)Product type:GuidanceProgramme:HealthTech guidancePublished: 29 November 2022
UroLift for treating lower urinary tract symptoms of benign prostatic hyperplasia (HTG578)Product type:GuidanceProgramme:HealthTech guidancePublished: 4 May 2021
The PLASMA system for transurethral resection and haemostasis of the prostate (HTG563)Product type:GuidanceProgramme:HealthTech guidancePublished: 6 January 2021
Axonics sacral neuromodulation system for treating refractory overactive bladder (HTG554)Product type:GuidanceProgramme:HealthTech guidancePublished: 3 September 2020
Rezum for treating lower urinary tract symptoms secondary to benign prostatic hyperplasia (HTG545)Product type:GuidanceProgramme:HealthTech guidancePublished: 24 June 2020